Amifostine is a
drug that can be administered with cytoprotective adjuvant
therapy to counteract the cytotoxic effects of prostate
cancer chemotherapy. Amifostine has the ability to differentiate
between healthy cells and tumor cells due to the biological
properties of each type of cell. Amifostine can act
like a shield for healthy cells during prostate cancer
chemotherapy. The protective affects of amifostine can
decrease the occurrence and severity of side effects.
|
